An interventional study of Active alarms from WARD software in Cancer, Chronic Obstructive Pulmonary Disease and Surgery-Complications, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-06.
Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Diagnostic
This aim of this study is to investigate whether active alerts during CVSM result in an increased number of diagnostic tests and treatments in complication free patients, hypothesizing that more interventions are performed in the CVSM-group than standard of care (EWS) group.
2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.
This study's enrollment of 700 is above the median of 66 across 1,837 interventional studies indexed under Lung Diseases, Obstructive.
Browse Lung Diseases, Obstructive studies →Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
-
Patients with continuous monitoring without active alerts from WARD.
Patients with continuous monitoring with active alerts from WARD.
Device: Active alarms from WARD software
Wireless continuous vital sign monitoring with real time staff alerts
Frequency of patients having at least one of the following tests/treatments:
* CT-scans * MRi-Scans * PET-Scans * X-ray (ordered by attending doctor, besides standard procedural investigations) * ultrasounds * Antibiotics (ordered by attending doctor, besides standard procedural treatment) * Arterial puncture * Gastro- colonoscopy * Dialysis * Central venous line (incl. dialysis catheter)
Time frame: 72 hours
The frequency of individual treatments and diagnostics:
Treatments: * Antibiotics (ordered by attending doctor, besides standard procedural treatment) * CPAP * blood-transfusion * IV-fluids * Dialysis * Naso-gastric tube (ordered by attending doctor, besides standard procedural treatment) * Central venous line (incl. dialysis catheter) Diagnostics: * Imaging CT, X-ray, MRI, PET, and ultrasound. * Blood tests: arterial blood gases, cultures, and other blood sample tests. * ECG * cultures from urine, sputum, swabs, and feces.
Time frame: 72 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rigshospitalet, Denmark